Institutional shares held 18,114
0 calls
0 puts
Total value of holdings $117K
$0 calls
$0 puts
Market Cap $74.2M
13,012,900 Shares Out.
Institutional ownership 0.14%
# of Institutions 3


Latest Institutional Activity in RGC

Top Purchases

Q3 2024
Ubs Group Ag Shares Held: 17.9K ($102K)
Q3 2024
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q3 2023
Tower Research Capital LLC (Trc) Shares Held: 85 ($485)
Q3 2023
Morgan Stanley Shares Held: 326 ($1.86K)
Q3 2023
Qube Research & Technologies LTD Shares Held: 13 ($74.1)

Top Sells

Q2 2022
Citigroup Inc Shares Held: 0 ($0)
Q4 2021
Schonfeld Strategic Advisors LLC Shares Held: 0 ($0)

About RGC

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.


Insider Transactions at RGC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on RGC

Follow Regencell Bioscience Holdings Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGC shares.

Notify only if

Insider Trading

Get notified when an Regencell Bioscience Holdings LTD insider buys or sells RGC shares.

Notify only if

News

Receive news related to Regencell Bioscience Holdings Ltd

Track Activities on RGC